MS patients may receive less frequent rituximab infusions without increasing their chances of relapse or disease progression, ...

A small molecule that blocks TYK2 in the brain showed promise for reducing disease activity in mouse models of multiple ...

Columnist Desiree Lama remembers how a best friend helped her with stressful assignments and RRMS symptoms in college.

People with multiple sclerosis (MS) may receive less frequent infusions of rituximab without increasing their chances of relapse or disease progression, according to a real-world study from Norway.

The AdventHealth Neuroscience Institute is testing IDP-023 for primary or nonactive secondary progressive multiple sclerosis ...

Barry Singer, MD, explains why setting realistic expectations about MS treatments is key to managing the disease effectively.

Columnist Ahna Crum spent years trying to go it alone. Now she knows that freedom comes when she's flocking together with ...

Sexual dysfunction was found to affect 80% of Iranian women with MS, with older age and lower education levels being key ...

Anne Rosales, living with MS, shares how partnering with your medical team empowers you to take charge of your health.

Aaron Boster, MD, shares three essential rules he points patients toward to safely evaluate alternative therapies for MS ...

Sanam Saeedi, MS health and life coach, shares why self-advocacy is essential and how to push for the care you deserve.

Treatment with high-dose vitamin D reduced disease activity in people with clinically isolated syndrome in a Phase 3 trial.